Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression
(Q44277460)
scientific article published in February 2003
scientific article published in February 2003
Language:
other details
| description | scientific article published in February 2003 |
External Links
| (P356) |
10.1016/S0145-2126(02)00085-1
|
| (P698) |
12526919
|